Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes
Waldemar Siemens, Gerhild Becker Clinic for Palliative Care, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany Introduction: Opioid-induced constipation (OIC) is a frequent adverse event that impairs patients’ quality of life. This artic...
Saved in:
Main Authors: | Siemens W (Author), Becker G (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide
by: Katri Elina Clemens, et al.
Published: (2010) -
Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation
by: David Farchadi, MD, MS, et al.
Published: (2023) -
The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020) -
Efficacy and safety of probiotics in Parkinson's constipation: A systematic review and meta-analysis
by: Li Xie, et al.
Published: (2023) -
Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspective
by: Fabio Lugoboni, et al.
Published: (2021)